Novo Nordisk A/S: all 1,444 studies

Page 13 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)CompletedNCT01009905
• A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedNCT01006057Phase 1
• Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 DiabeticsCompletedNCT01002768Phase 1
• A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 DiabeticsCompletedNCT00993304Phase 1
• Investigation of the Response Relationship of NN5401 in Type 1 DiabeticsCompletedNCT00993096Phase 1
• Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 DiabeticsCompletedNCT00992537Phase 1
• Safety and Tolerability of NN9068 in Healthy Male VolunteersCompletedNCT00983021Phase 1
• A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese VolunteersCompletedNCT00978393Phase 1
• A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver FunctionCompletedNCT00976326Phase 1
• Comparison of Two NN1250 Formulations in Healthy VolunteersCompletedNCT00966368Phase 1
• A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 DiabeticsCompletedNCT00964964Phase 1
• A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 DiabetesCompletedNCT00964418Phase 1
• A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 DiabetesCompletedNCT00961324Phase 1
• Observational Prospective Study on Patients Treated With Norditropin®CompletedNCT00960128
• Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy VolunteersCompletedNCT00959101Phase 1
• Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia BCompletedNCT00956345Phase 1
• A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male VolunteersCompletedNCT00951873Phase 1
• Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With InhibitorsCompletedNCT00951405Phase 2
• Safety of Liraglutide in Pediatric Patients With Type 2 DiabetesCompletedNCT00943501Phase 1
• A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth HormoneCompletedNCT00936403Phase 2
• An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®CompletedNCT00934063
• A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of SomatropinCompletedNCT00931476Phase 1
• Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and BCompletedNCT00922792Phase 1
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in KoreaCompletedNCT00918151
• A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese SubjectsCompletedNCT00897169Phase 1
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in TaiwanCompletedNCT00887874
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in MalaysiaCompletedNCT00877526
• A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in PhilippinesCompletedNCT00874159
• Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin AnaloguesCompletedNCT00873639
• Examination of the Effects of Liraglutide on the Mode of Action of Insulin DetemirCompletedNCT00873223Phase 1
• Comparison of 2 NovoFine® Needles on the Reflux of InsulinCompletedNCT00872560Phase 3
• Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long NeedlesCompletedNCT00871416Phase 3
• Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic MedicationCompletedNCT00869908
• Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin TreatmentCompletedNCT00865397
• Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia DatabaseCompletedNCT00853086
• Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian SubjectsCompletedNCT00851773Phase 1
• Observational Study on Levemir® in Obese Diabetic PatientsCompletedNCT00849342
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney DiseaseWithdrawnNCT00849316
• Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in MacedoniaCompletedNCT00842894
• An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East CountriesCompletedNCT00842192
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in BangladeshCompletedNCT00839878
• Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsCompletedNCT00837356Phase 1
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in SingaporeCompletedNCT00836030
• Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes PatientsCompletedNCT00834262
• Effect of Renal Impairment on the Pharmacokinetics of NN9535CompletedNCT00833716Phase 1
• Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 DiabetesCompletedNCT00832182Phase 3
• Observational Study to Evaluate the Safety of Levemir® in Type 2 DiabetesCompletedNCT00825643
• Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesCompletedNCT00825253Phase 1
• Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCompletedNCT00824668Phase 1
• Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid ArthritisCompletedNCT00818064Phase 1
• A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male SubjectsCompletedNCT00813020Phase 1
• Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes SubjectsCompletedNCT00806936
• Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®CompletedNCT00806897
• Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes MellitusCompletedNCT00806858
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in ThailandCompletedNCT00805922
• Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedNCT00799448Phase 4
• Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.CompletedNCT00793273
• Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsCompletedNCT00791895Phase 4
• An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of DiabetesCompletedNCT00789711
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndonesiaCompletedNCT00788853
• Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) SubjectsCompletedNCT00787878
• Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix InsulinCompletedNCT00775736
• Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT00771680
• To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or PlaceboCompletedNCT00761540Phase 1
• Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaCompletedNCT00760448Phase 1
• Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsCompletedNCT00755833
• Switch From Metformin Monotherapy to a Bitherapy With Metformin and RepaglinideCompletedNCT00745433
• Observational Study on Safety of Self-titration of Once Daily Levemir®CompletedNCT00740519
• An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 DiabetesCompletedNCT00738153
• Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00737776
• Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 DiabetesCompletedNCT00735501
• Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 DiabetesCompletedNCT00729898
• Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese VolunteersWithdrawnNCT00728455Phase 1
• Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 DiabetesCompletedNCT00725036Phase 3
• Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083CompletedNCT00722540Phase 1
• Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic AgentsCompletedNCT00715780
• Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083CompletedNCT00715689Phase 2
• Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 DiabetesCompletedNCT00715663
• Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of DiabetesCompletedNCT00715351
• Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 DiabetesCompletedNCT00712478
• Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IXCompletedNCT00710619
• Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 DiabetesCompletedNCT00709917
• Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®CompletedNCT00709683
• Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes MellitusCompletedNCT00709475
• Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00706017
• Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi SyndromeCompletedNCT00705172
• Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 DiabetesCompletedNCT00704574
• Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 DiabetesCompletedNCT00704223
• Observational Study to Evaluate the Safety While Using Levemir®CompletedNCT00701155
• Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlCompletedNCT00700960
• Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNCT00700830
• Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 DiabetesCompletedNCT00700765
• An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised SubjectsCompletedNCT00700648
• Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 DiabetesCompletedNCT00699179
• Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 DiabetesCompletedNCT00698802Phase 2
• An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic TreatmentCompletedNCT00698269
• Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 DiabetesCompletedNCT00698126
• Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 DiabeticsCompletedNCT00697450
• Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in GermanyCompletedNCT00697320
• An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 TreatmentCompletedNCT00696995

← Novo Nordisk A/S overview and focus areas